Global Oligonucleotides Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 102953
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Chemical and Material
Buy @ $3500

Market Overview

The Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Oligonucleotides market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 1685.8 million by 2025, from USD 1165.5 million in 2019.

Market segmentation

Oligonucleotides market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oligonucleotides market has been segmented into

DNA Oligos

RNA Oligos

By Application, Oligonucleotides has been segmented into:

Pharmaceutical

Research

Diagnostic

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Oligonucleotides market presented in the report. This section sheds light on the sales growth of different regional and country-level Oligonucleotides markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oligonucleotides market.

The report offers in-depth assessment of the growth and other aspects of the Oligonucleotides market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, etc.)

Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Oligonucleotides Market Share Analysis

Oligonucleotides competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oligonucleotides sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oligonucleotides sales, revenue and market share for each player covered in this report.

The major players covered in Oligonucleotides are:

Integrated DNA Technologies

GenScript

Eurofins Genomics

Agilent

Nitto Denko Avecia Inc

Sigma-aldrich

GeneDesign

Eurogentec S.A

L.G.C Biosearch Technologies

BBI Life Sciences

Creative Biogene

TriLink BioTechnologies

General Biosystems

Twist Bioscience

SGS DNA

LC Sciences

Among other players domestic and global, Oligonucleotides market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Oligonucleotides product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Oligonucleotides, with price, sales, revenue and global market share of Oligonucleotides in 2018 and 2019.

Chapter 3, the Oligonucleotides competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Oligonucleotides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Oligonucleotides market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Oligonucleotides sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Oligonucleotides Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Oligonucleotides Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 DNA Oligos

1.2.3 RNA Oligos

1.3 Market Analysis by Application

1.3.1 Overview: Global Oligonucleotides Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Pharmaceutical

1.3.3 Research

1.3.4 Diagnostic

1.4 Overview of Global Oligonucleotides Market

1.4.1 Global Oligonucleotides Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Integrated DNA Technologies

2.1.1 Integrated DNA Technologies Details

2.1.2 Integrated DNA Technologies Major Business

2.1.3 Integrated DNA Technologies SWOT Analysis

2.1.4 Integrated DNA Technologies Product and Services

2.1.5 Integrated DNA Technologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 GenScript

2.2.1 GenScript Details

2.2.2 GenScript Major Business

2.2.3 GenScript SWOT Analysis

2.2.4 GenScript Product and Services

2.2.5 GenScript Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Eurofins Genomics

2.3.1 Eurofins Genomics Details

2.3.2 Eurofins Genomics Major Business

2.3.3 Eurofins Genomics SWOT Analysis

2.3.4 Eurofins Genomics Product and Services

2.3.5 Eurofins Genomics Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Agilent

2.4.1 Agilent Details

2.4.2 Agilent Major Business

2.4.3 Agilent SWOT Analysis

2.4.4 Agilent Product and Services

2.4.5 Agilent Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Nitto Denko Avecia Inc

2.5.1 Nitto Denko Avecia Inc Details

2.5.2 Nitto Denko Avecia Inc Major Business

2.5.3 Nitto Denko Avecia Inc SWOT Analysis

2.5.4 Nitto Denko Avecia Inc Product and Services

2.5.5 Nitto Denko Avecia Inc Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Sigma-aldrich

2.6.1 Sigma-aldrich Details

2.6.2 Sigma-aldrich Major Business

2.6.3 Sigma-aldrich Product and Services

2.6.4 Sigma-aldrich Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 GeneDesign

2.7.1 GeneDesign Details

2.7.2 GeneDesign Major Business

2.7.3 GeneDesign Product and Services

2.7.4 GeneDesign Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Eurogentec S.A

2.8.1 Eurogentec S.A Details

2.8.2 Eurogentec S.A Major Business

2.8.3 Eurogentec S.A Product and Services

2.8.4 Eurogentec S.A Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 L.G.C Biosearch Technologies

2.9.1 L.G.C Biosearch Technologies Details

2.9.2 L.G.C Biosearch Technologies Major Business

2.9.3 L.G.C Biosearch Technologies Product and Services

2.9.4 L.G.C Biosearch Technologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 BBI Life Sciences

2.10.1 BBI Life Sciences Details

2.10.2 BBI Life Sciences Major Business

2.10.3 BBI Life Sciences Product and Services

2.10.4 BBI Life Sciences Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Creative Biogene

2.11.1 Creative Biogene Details

2.11.2 Creative Biogene Major Business

2.11.3 Creative Biogene Product and Services

2.11.4 Creative Biogene Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.12 TriLink BioTechnologies

2.12.1 TriLink BioTechnologies Details

2.12.2 TriLink BioTechnologies Major Business

2.12.3 TriLink BioTechnologies Product and Services

2.12.4 TriLink BioTechnologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.13 General Biosystems

2.13.1 General Biosystems Details

2.13.2 General Biosystems Major Business

2.13.3 General Biosystems Product and Services

2.13.4 General Biosystems Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.14 Twist Bioscience

2.14.1 Twist Bioscience Details

2.14.2 Twist Bioscience Major Business

2.14.3 Twist Bioscience Product and Services

2.14.4 Twist Bioscience Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.15 SGS DNA

2.15.1 SGS DNA Details

2.15.2 SGS DNA Major Business

2.15.3 SGS DNA Product and Services

2.15.4 SGS DNA Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.16 LC Sciences

2.16.1 LC Sciences Details

2.16.2 LC Sciences Major Business

2.16.3 LC Sciences Product and Services

2.16.4 LC Sciences Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Oligonucleotides Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Oligonucleotides Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Oligonucleotides Manufacturer Market Share in 2019

3.3.2 Top 6 Oligonucleotides Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Oligonucleotides Sales, Revenue and Market Share by Regions

4.1.1 Global Oligonucleotides Sales and Market Share by Regions (2015-2020)

4.1.2 Global Oligonucleotides Revenue and Market Share by Regions (2015-2020)

4.2 North America Oligonucleotides Sales and Growth Rate (2015-2020)

4.3 Europe Oligonucleotides Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Oligonucleotides Sales and Growth Rate (2015-2020)

4.5 South America Oligonucleotides Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Oligonucleotides Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Oligonucleotides Sales, Revenue and Market Share by Country

5.1.1 North America Oligonucleotides Sales and Market Share by Country (2015-2020)

5.1.2 North America Oligonucleotides Revenue and Market Share by Country (2015-2020)

5.2 United States Oligonucleotides Sales and Growth Rate (2015-2020)

5.3 Canada Oligonucleotides Sales and Growth Rate (2015-2020)

5.4 Mexico Oligonucleotides Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Oligonucleotides Sales, Revenue and Market Share by Country

6.1.1 Europe Oligonucleotides Sales and Market Share by Country (2015-2020)

6.1.2 Europe Oligonucleotides Revenue and Market Share by Country (2015-2020)

6.2 Germany Oligonucleotides Sales and Growth Rate (2015-2020)

6.3 UK Oligonucleotides Sales and Growth Rate (2015-2020)

6.4 France Oligonucleotides Sales and Growth Rate (2015-2020)

6.5 Russia Oligonucleotides Sales and Growth Rate (2015-2020)

6.6 Italy Oligonucleotides Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Oligonucleotides Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Oligonucleotides Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Oligonucleotides Revenue and Market Share by Regions (2015-2020)

7.2 China Oligonucleotides Sales and Growth Rate (2015-2020)

7.3 Japan Oligonucleotides Sales and Growth Rate (2015-2020)

7.4 Korea Oligonucleotides Sales and Growth Rate (2015-2020)

7.5 India Oligonucleotides Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Oligonucleotides Sales and Growth Rate (2015-2020)

7.7 Australia Oligonucleotides Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Oligonucleotides Sales, Revenue and Market Share by Country

8.1.1 South America Oligonucleotides Sales and Market Share by Country (2015-2020)

8.1.2 South America Oligonucleotides Revenue and Market Share by Country (2015-2020)

8.2 Brazil Oligonucleotides Sales and Growth Rate (2015-2020)

8.3 Argentina Oligonucleotides Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Oligonucleotides Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Oligonucleotides Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Oligonucleotides Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Oligonucleotides Sales and Growth Rate (2015-2020)

9.3 Turkey Oligonucleotides Sales and Growth Rate (2015-2020)

9.4 Egypt Oligonucleotides Sales and Growth Rate (2015-2020)

9.5 South Africa Oligonucleotides Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Oligonucleotides Sales and Market Share by Type (2015-2020)

10.2 Global Oligonucleotides Revenue and Market Share by Type (2015-2020)

10.3 Global Oligonucleotides Price by Type (2015-2020)

11 Global Oligonucleotides Market Segment by Application

11.1 Global Oligonucleotides Sales Market Share by Application (2015-2020)

11.2 Global Oligonucleotides Revenue Market Share by Application (2015-2020)

11.3 Global Oligonucleotides Price by Application (2015-2020)

12 Market Forecast

12.1 Global Oligonucleotides Sales, Revenue and Growth Rate (2021-2025)

12.2 Oligonucleotides Market Forecast by Regions (2021-2025)

12.2.1 North America Oligonucleotides Market Forecast (2021-2025)

12.2.2 Europe Oligonucleotides Market Forecast (2021-2025)

12.2.3 Asia-Pacific Oligonucleotides Market Forecast (2021-2025)

12.2.4 South America Oligonucleotides Market Forecast (2021-2025)

12.2.5 Middle East & Africa Oligonucleotides Market Forecast (2021-2025)

12.3 Oligonucleotides Market Forecast by Type (2021-2025)

12.3.1 Global Oligonucleotides Sales Forecast by Type (2021-2025)

12.3.2 Global Oligonucleotides Market Share Forecast by Type (2021-2025)

12.4 Oligonucleotides Market Forecast by Application (2021-2025)

12.4.1 Global Oligonucleotides Sales Forecast by Application (2021-2025)

12.4.2 Global Oligonucleotides Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Oligonucleotides Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Oligonucleotides by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Oligonucleotides Market Size and Growth Estimation in Various Scenarios in 2020

Table 4. Global Oligonucleotides Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 5. Market Opportunities in Next Few Years

Table 6. Market Risks Analysis

Table 7. Market Drivers

Table 8. Integrated DNA Technologies Basic Information, Manufacturing Base and Competitors

Table 9. Integrated DNA Technologies Oligonucleotides Major Business

Table 10. Integrated DNA Technologies Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 11. Integrated DNA Technologies SWOT Analysis

Table 12. Integrated DNA Technologies Oligonucleotides Product and Services

Table 13. Integrated DNA Technologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 14. GenScript Basic Information, Manufacturing Base and Competitors

Table 15. GenScript Oligonucleotides Major Business

Table 16. GenScript Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 17. GenScript SWOT Analysis

Table 18. GenScript Oligonucleotides Product and Services

Table 19. GenScript Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 20. Eurofins Genomics Basic Information, Manufacturing Base and Competitors

Table 21. Eurofins Genomics Oligonucleotides Major Business

Table 22. Eurofins Genomics Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 23. Eurofins Genomics SWOT Analysis

Table 24. Eurofins Genomics Oligonucleotides Product and Services

Table 25. Eurofins Genomics Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 26. Agilent Basic Information, Manufacturing Base and Competitors

Table 27. Agilent Oligonucleotides Major Business

Table 28. Agilent Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 29. Agilent SWOT Analysis

Table 30. Agilent Oligonucleotides Product and Services

Table 31. Agilent Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 32. Nitto Denko Avecia Inc Basic Information, Manufacturing Base and Competitors

Table 33. Nitto Denko Avecia Inc Oligonucleotides Major Business

Table 34. Nitto Denko Avecia Inc Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 35. Nitto Denko Avecia Inc SWOT Analysis

Table 36. Nitto Denko Avecia Inc Oligonucleotides Product and Services

Table 37. Nitto Denko Avecia Inc Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 38. Sigma-aldrich Basic Information, Manufacturing Base and Competitors

Table 39. Sigma-aldrich Oligonucleotides Major Business

Table 40. Sigma-aldrich Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 41. Sigma-aldrich SWOT Analysis

Table 42. Sigma-aldrich Oligonucleotides Product and Services

Table 43. Sigma-aldrich Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 44. GeneDesign Basic Information, Manufacturing Base and Competitors

Table 45. GeneDesign Oligonucleotides Major Business

Table 46. GeneDesign Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 47. GeneDesign SWOT Analysis

Table 48. GeneDesign Oligonucleotides Product and Services

Table 49. GeneDesign Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 50. Eurogentec S.A Basic Information, Manufacturing Base and Competitors

Table 51. Eurogentec S.A Oligonucleotides Major Business

Table 52. Eurogentec S.A Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 53. Eurogentec S.A SWOT Analysis

Table 54. Eurogentec S.A Oligonucleotides Product and Services

Table 55. Eurogentec S.A Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 56. L.G.C Biosearch Technologies Basic Information, Manufacturing Base and Competitors

Table 57. L.G.C Biosearch Technologies Oligonucleotides Major Business

Table 58. L.G.C Biosearch Technologies Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 59. L.G.C Biosearch Technologies SWOT Analysis

Table 60. L.G.C Biosearch Technologies Oligonucleotides Product and Services

Table 61. L.G.C Biosearch Technologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 62. BBI Life Sciences Basic Information, Manufacturing Base and Competitors

Table 63. BBI Life Sciences Oligonucleotides Major Business

Table 64. BBI Life Sciences Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 65. BBI Life Sciences SWOT Analysis

Table 66. BBI Life Sciences Oligonucleotides Product and Services

Table 67. BBI Life Sciences Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 68. Creative Biogene Basic Information, Manufacturing Base and Competitors

Table 69. Creative Biogene Oligonucleotides Major Business

Table 70. Creative Biogene Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 71. Creative Biogene SWOT Analysis

Table 72. Creative Biogene Oligonucleotides Product and Services

Table 73. Creative Biogene Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 74. TriLink BioTechnologies Basic Information, Manufacturing Base and Competitors

Table 75. TriLink BioTechnologies Oligonucleotides Major Business

Table 76. TriLink BioTechnologies Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 77. TriLink BioTechnologies SWOT Analysis

Table 78. TriLink BioTechnologies Oligonucleotides Product and Services

Table 79. TriLink BioTechnologies Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 80. General Biosystems Basic Information, Manufacturing Base and Competitors

Table 81. General Biosystems Oligonucleotides Major Business

Table 82. General Biosystems Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 83. General Biosystems SWOT Analysis

Table 84. General Biosystems Oligonucleotides Product and Services

Table 85. General Biosystems Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 86. Twist Bioscience Basic Information, Manufacturing Base and Competitors

Table 87. Twist Bioscience Oligonucleotides Major Business

Table 88. Twist Bioscience Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 89. Twist Bioscience SWOT Analysis

Table 90. Twist Bioscience Oligonucleotides Product and Services

Table 91. Twist Bioscience Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 92. SGS DNA Basic Information, Manufacturing Base and Competitors

Table 93. SGS DNA Oligonucleotides Major Business

Table 94. SGS DNA Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 95. SGS DNA SWOT Analysis

Table 96. SGS DNA Oligonucleotides Product and Services

Table 97. SGS DNA Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 98. LC Sciences Basic Information, Manufacturing Base and Competitors

Table 99. LC Sciences Oligonucleotides Major Business

Table 100. LC Sciences Oligonucleotides Total Revenue (USD Million) (2018-2019)

Table 101. LC Sciences SWOT Analysis

Table 102. LC Sciences Oligonucleotides Product and Services

Table 103. LC Sciences Oligonucleotides Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 104. Global Oligonucleotides Sales by Manufacturer (2018-2019) (Million MT)

Table 105. Global Oligonucleotides Revenue by Manufacturer (2018-2019) (USD Million)

Table 106. Global Oligonucleotides Sales by Regions (2015-2020) (Million MT)

Table 107. Global Oligonucleotides Sales Market Share by Regions (2015-2020)

Table 108. Global Oligonucleotides Revenue by Regions (2015-2020) (USD Million)

Table 109. North America Oligonucleotides Sales by Countries (2015-2020) (Million MT)

Table 110. North America Oligonucleotides Sales Market Share by Countries (2015-2020)

Table 111. North America Oligonucleotides Revenue by Countries (2015-2020) (USD Million)

Table 112. North America Oligonucleotides Revenue Market Share by Countries (2015-2020)

Table 113. Europe Oligonucleotides Sales by Countries (2015-2020) (Million MT)

Table 114. Europe Oligonucleotides Sales Market Share by Countries (2015-2020)

Table 115. Europe Oligonucleotides Revenue by Countries (2015-2020) (USD Million)

Table 116. Asia-Pacific Oligonucleotides Sales by Regions (2015-2020) (Million MT)

Table 117. Asia-Pacific Oligonucleotides Sales Market Share by Regions (2015-2020)

Table 118. Asia-Pacific Oligonucleotides Revenue by Regions (2015-2020) (USD Million)

Table 119. South America Oligonucleotides Sales by Countries (2015-2020) (Million MT)

Table 120. South America Oligonucleotides Sales Market Share by Countries (2015-2020)

Table 121. South America Oligonucleotides Revenue by Countries (2015-2020) (USD Million)

Table 122. South America Oligonucleotides Revenue Market Share by Countries (2015-2020)

Table 123. Middle East & Africa Oligonucleotides Sales by Countries (2015-2020) (Million MT)

Table 124. Middle East & Africa Oligonucleotides Sales Market Share by Countries (2015-2020)

Table 125. Middle East & Africa Oligonucleotides Revenue by Countries (2015-2020) (USD Million)

Table 126. Middle East & Africa Oligonucleotides Revenue Market Share by Countries (2015-2020)

Table 127. Global Oligonucleotides Sales by Type (2015-2020) (Million MT)

Table 128. Global Oligonucleotides Sales Share by Type (2015-2020)

Table 129. Global Oligonucleotides Revenue by Type (2015-2020) (USD Million)

Table 130. Global Oligonucleotides Revenue Share by Type (2015-2020)

Table 131. Global Oligonucleotides Sales by Application (2015-2020) (Million MT)

Table 132. Global Oligonucleotides Sales Share by Application (2015-2020)

Table 133. Global Oligonucleotides Sales Forecast by Regions (2021-2025) (Million MT)

Table 134. Global Oligonucleotides Market Share Forecast by Regions (2021-2025)

Table 135. Global Oligonucleotides Sales Forecast by Type (2021-2025) (Million MT)

Table 136. Global Oligonucleotides Market Share Forecast by Type (2021-2025)

Table 137. Global Oligonucleotides Sales Forecast by Application (2021-2025)

Table 138. Global Oligonucleotides Market Share Forecast by Application (2021-2025)

Table 139. Direct Channel Pros & Cons

Table 140. Indirect Channel Pros & Cons

Table 141. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Oligonucleotides Picture

Figure 2. Global Sales Market Share of Oligonucleotides by Type in 2019

Figure 3. DNA Oligos Picture

Figure 4. RNA Oligos Picture

Figure 5. Oligonucleotides Sales Market Share by Application in 2019

Figure 6. Pharmaceutical Picture

Figure 7. Research Picture

Figure 8. Diagnostic Picture

Figure 9. Global Oligonucleotides Market Status and Outlook (2015-2025) (USD Million)

Figure 10. United States Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 11. Canada Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 12. Mexico Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 13. Germany Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 14. France Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 15. UK Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 16. Russia Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Italy Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 18. China Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 19. Japan Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 20. Korea Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 21. India Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 22. Southeast Asia Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Australia Oligonucleotides Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 24. Brazil Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 25. Egypt Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Saudi Arabia Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 27. South Africa Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 28. Turkey Oligonucleotides Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Global Oligonucleotides Sales Market Share by Manufacturer in 2019

Figure 30. Global Oligonucleotides Revenue Market Share by Manufacturer in 2019

Figure 31. Top 3 Oligonucleotides Manufacturer (Revenue) Market Share in 2019

Figure 32. Top 6 Oligonucleotides Manufacturer (Revenue) Market Share in 2019

Figure 33. Key Manufacturer Market Share Trend

Figure 34. Global Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 35. Global Oligonucleotides Revenue and Growth Rate (2015-2020) (USD Million)

Figure 36. Global Oligonucleotides Revenue Market Share by Regions (2015-2020)

Figure 37. Global Oligonucleotides Revenue Market Share by Regions in 2018

Figure 38. North America Oligonucleotides Sales and Growth Rate (2015-2020)

Figure 39. Europe Oligonucleotides Sales and Growth Rate (2015-2020)

Figure 40. Asia-Pacific Oligonucleotides Sales and Growth Rate (2015-2020)

Figure 41. South America Oligonucleotides Sales and Growth Rate (2015-2020)

Figure 42. Middle East & Africa Oligonucleotides Sales and Growth Rate (2015-2020)

Figure 43. North America Oligonucleotides Revenue and Growth Rate (2015-2020) (USD Million)

Figure 44. North America Oligonucleotides Sales Market Share by Countries (2015-2020)

Figure 45. North America Oligonucleotides Sales Market Share by Countries in 2018

Figure 46. North America Oligonucleotides Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 47. North America Oligonucleotides Revenue Market Share by Countries in 2018

Figure 48. United States Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 49. Canada Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 50. Mexico Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 51. Europe Oligonucleotides Revenue and Growth Rate (2015-2020) (USD Million)

Figure 52. Europe Oligonucleotides Revenue Market Share by Countries (2015-2020)

Figure 53. Europe Oligonucleotides Revenue Market Share by Countries in 2019

Figure 54. Germany Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 55. UK Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 56. France Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 57. Russia Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 58. Italy Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 59. Asia-Pacific Oligonucleotides Revenue and Growth Rate (2015-2020) (USD Million)

Figure 60. Asia-Pacific Oligonucleotides Sales Market Share by Regions 2019

Figure 61. Asia-Pacific Oligonucleotides Revenue Market Share by Regions 2019

Figure 62. China Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 63. Japan Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 64. Korea Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 65. India Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 66. Southeast Asia Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 67. South America Oligonucleotides Revenue and Growth Rate (2015-2020) (USD Million)

Figure 68. South America Oligonucleotides Sales Market Share by Countries in 2019

Figure 69. South America Oligonucleotides Revenue Market Share by Countries in 2019

Figure 70. Brazil Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 71. Argentina Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 72. Middle East and Africa Oligonucleotides Revenue and Growth Rate (2015-2020) (USD Million)

Figure 73. Middle East and Africa Oligonucleotides Sales Market Share by Countries in 2019

Figure 74. Middle East and Africa Oligonucleotides Revenue Market Share by Countries (2015-2020)

Figure 75. Middle East and Africa Oligonucleotides Revenue Market Share by Countries in 2019

Figure 76. Saudi Arabia Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 77. Egypt Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 78. Turkey Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 79. South Africa Oligonucleotides Sales and Growth Rate (2015-2020) (Million MT)

Figure 80. Global Oligonucleotides Sales and Growth Rate (2021-2025) (Million MT)

Figure 81. Global Oligonucleotides Revenue and Growth Rate (2021-2025) (USD Million)

Figure 82. North America Sales Oligonucleotides Market Forecast (2021-2025) (Million MT)

Figure 83. Europe Sales Oligonucleotides Market Forecast (2021-2025) (Million MT)

Figure 84. Asia-Pacific Sales Oligonucleotides Market Forecast (2021-2025) (Million MT)

Figure 85. South America Sales Oligonucleotides Market Forecast (2021-2025) (Million MT)

Figure 86. Middle East & Africa Sales Oligonucleotides Market Forecast (2021-2025) (Million MT)

Figure 87. Sales Channel: Direct Channel vs Indirect Channel